Details for New Drug Application (NDA): 084324
✉ Email this page to a colleague
The generic ingredient in HYDROCHLOROTHIAZIDE is hydralazine hydrochloride; hydrochlorothiazide; reserpine. There are twenty-one drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide; reserpine profile page.
Summary for 084324
Tradename: | HYDROCHLOROTHIAZIDE |
Applicant: | Lannett Co Inc |
Ingredient: | hydrochlorothiazide |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 084324
Physiological Effect | Increased Diuresis |
Medical Subject Heading (MeSH) Categories for 084324
Suppliers and Packaging for NDA: 084324
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
HYDROCHLOROTHIAZIDE | hydrochlorothiazide | TABLET;ORAL | 084324 | ANDA | Lannett Company, Inc. | 0527-1414 | 0527-1414-01 | 100 TABLET in 1 BOTTLE, PLASTIC (0527-1414-01) |
HYDROCHLOROTHIAZIDE | hydrochlorothiazide | TABLET;ORAL | 084324 | ANDA | Lannett Company, Inc. | 0527-1414 | 0527-1414-10 | 1000 TABLET in 1 BOTTLE, PLASTIC (0527-1414-10) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription